Sacha Gnjatic
Impact in
- Immunology top 0.05%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- Oncology top 0.05%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 157
- Immunotherapy and Immune Responses 144
- T-cell and B-cell Immunology 39
- Immune Cell Function and Interaction 36
- Oncology 91
- Cancer Immunotherapy and Biomarkers 61
- CAR-T cell therapy research 30
- Co-authors
- Lloyd J. Old (80 shared papers)Gerd Ritter (56 shared papers)Achim A. Jungbluth (41 shared papers)Yao‐Tseng Chen (18 shared papers)Kunle Odunsi (24 shared papers)Elke Jäger (26 shared papers)Shashikant Lele (11 shared papers)Feng Qian (7 shared papers)
- Journals
- Journal of Clinical Oncology (28 papers)Proceedings of the National Academy of Sciences (19 papers)Blood (16 papers)Cancer Research (11 papers)Journal for ImmunoTherapy of Cancer (11 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Sacha Gnjatic
217 papers receiving 16.8k citations
Sacha Gnjatic's Hit Papers
Peers
Comparison fields: 5 of 132
- Immunology 10.4k
- Oncology 8.4k
- Molecular Biology 4.3k
- Radiology, Nuclear Medicine and Imaging 1.1k
- Cancer Research 719
Countries citing papers authored by Sacha Gnjatic
This map shows the geographic impact of Sacha Gnjatic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sacha Gnjatic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sacha Gnjatic more than expected).
Fields of papers citing papers by Sacha Gnjatic
This network shows the impact of papers produced by Sacha Gnjatic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sacha Gnjatic. The network helps show where Sacha Gnjatic may publish in the future.
Co-authors
The 25 scholars most cited alongside Sacha Gnjatic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 224 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Intraepithelial CD8 + tumor-infiltrating lymphocytes and a high CD8 + /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer Hit paper breakdown → | 2005 | 1888 |
| 2 | PD-L1 as a biomarker of response to immune-checkpoint inhibitors Hit paper breakdown → | 2021 | 1040 |
| 3 | Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1 Hit paper breakdown → | 2008 | 710 |
| 4 | Tumor-infiltrating NY-ESO-1–specific CD8 + T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer Hit paper breakdown → | 2010 | 698 |
| 5 | Radiotherapy induces responses of lung cancer to CTLA-4 blockade Hit paper breakdown → | 2018 | 664 |
| 6 | Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer Hit paper breakdown → | 2014 | 606 |
| 7 | 2007 | 402 | |
| 8 | 2000 | 363 | |
| 9 | 2000 | 337 | |
| 10 | 2011 | 322 | |
| 11 | 2013 | 311 | |
| 12 | 2008 | 297 | |
| 13 | 2005 | 293 | |
| 14 | 2006 | 281 | |
| 15 | 2008 | 268 | |
| 16 | Integrated NY-ESO-1 antibody and CD8 + T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab Hit paper breakdown → | 2011 | 255 |
| 17 | 2016 | 224 | |
| 18 | 2007 | 215 | |
| 19 | NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer. | 2003 | 209 |
| 20 | 2014 | 207 |
About Sacha Gnjatic
Sacha Gnjatic is a scholar working on Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 224 papers that have together received 17.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (144 papers), Cancer Immunotherapy and Biomarkers (61 papers), vaccines and immunoinformatics approaches (40 papers), T-cell and B-cell Immunology (39 papers), Immune Cell Function and Interaction (36 papers), CAR-T cell therapy research (30 papers), Monoclonal and Polyclonal Antibodies Research (19 papers) and RNA Interference and Gene Delivery (16 papers). The work is most often cited by research in Immunology (10.4k citations), Oncology (8.4k citations), Molecular Biology (4.3k citations), Radiology, Nuclear Medicine and Imaging (1.1k citations) and Cancer Research (719 citations). Sacha Gnjatic has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Lloyd J. Old, Gerd Ritter, Achim A. Jungbluth, Yao‐Tseng Chen, Kunle Odunsi, Elke Jäger, Shashikant Lele, Feng Qian, Hiroyoshi Nishikawa and Alexander Knuth. Their work appears in journals such as Journal of Clinical Oncology, Proceedings of the National Academy of Sciences, Blood, Cancer Research and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.